An investigation for investors in Zosano Pharma Corp (NASDAQ:ZSAN) shares was announced over potential securities laws violations by Zosano Pharma in connection certain financial statements.
Investors who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Zosano Pharma Corp (NASDAQ:ZSAN) concerning whether a series of statements by Zosano Pharma Corp regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Fremont, CA based Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Zosano Pharma Corp went public in January 2015 and shares of Zosano Pharma Corp (NASDAQ:ZSAN) grew to as high as $11.67 per share in March 2015. Since then shares of Zosano Pharma Corp (NASDAQ:ZSAN) declined to as low as $2.00 per share on January 20, 2016.
On February 2, 2016, NASDASQ:ZSAN shares closed at $2.35 per share.
Those who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com